By Elias Schisgall
Oracle reported a higher profit, buoyed by strong cloud revenue, but logged a decline in software revenue and said the buildout of its artificial-intelligence data-center infrastructure would pressure near-term margins. The stock declined 9.5%, to $182.20, in after-hours trading on Wednesday.
Oxford Industries reported a lower profit, citing the effects of tariff costs and macroeconomic pressures weighing on consumer sentiment. Shares fell 8.7%, to $39.50, after the bell.
Humacyte reported that its bioengineered blood vessel met a primary endpoint in a Phase 3 trial, but announced plans to launch an underwritten public stock offering. The stock was off 12%, to $1.18.
PureCycle Technologies said it would launch a $145 million stock offering and sell $250 million worth of convertible senior notes due 2032. Shares were down 14%, to $8.55.
Write to Elias Schisgall at elias.schisgall@wsj.com
(END) Dow Jones Newswires
June 10, 2026 19:04 ET (23:04 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.